Publication | Open Access
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
1.1K
Citations
25
References
2020
Year
ClinicalTrials.gov Identifier: NCT02494583.
| Year | Citations | |
|---|---|---|
Page 1
Page 1